Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin + capecitabine vs irinotecan + capecitabine in elderly advanced colorectal cancer
2004-001159-12Phase 2Active
- Sponsor
- San Carlo Hospital
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in colorectal cancer (CRC) comparing Oxaliplatin + capecitabine with Irinotecan + capecitabine (2 arms). Started May 2009; status: active.
02
Drugs
oxaliplatincapecitabineirinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2004-001159-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001159-12.